Search This Blog

Friday, November 1, 2019

Biohaven Pharmaceuticals EPS misses by $0.54

Biohaven Pharmaceuticals (NYSE:BHVN): Q3 GAAP EPS of -$2.04 misses by $0.54.
Cash balance of $416.6M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)